{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-03",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "spl_product_data_elements": [
        "Lidomax Lidomax LIDOCAINE LIDOCAINE WATER HYDROXYETHYLCELLULOSE PHENOXYETHANOL ETHYLHEXYLGLYCERIN SODIUM HYDROXIDE LACTIC ACID"
      ],
      "description": [
        "DESCRIPTION Lidomax™ is a topical gel containing Lidocaine Hydrochloride 2%, a local anesthetic. It is intended for topical application to intact skin."
      ],
      "indications_and_usage": [
        "INDICATIONS AND USAGE Lidomax™ is indicated for topical analgesia as directed by a healthcare provider."
      ],
      "warnings": [
        "WARNINGS For external use only. Not for ophthalmic use. Avoid contact with eyes. Do not use if allergic to lidocaine or any components of the formulation. Keep out of reach of children."
      ],
      "dosage_and_administration": [
        "DOSAGE AND ADMINISTRATION Apply a thin layer to the affected area 3 to 4 times daily or as directed by a healthcare provider. For external use only."
      ],
      "how_supplied": [
        "HOW SUPPLIED Lidomax™ (Lidocaine HCl 2%) is supplied as a clear topical gel in a 3 oz (85 g) tube. NDC 85477-304-07"
      ],
      "package_label_principal_display_panel": [
        "PRINCIPAL DISPLAY PANEL Store at 25°C (77°F); excursions permitted to 15°–30°C (59°–86°F). [See USP Controlled Room Temperature]. Keep container tightly closed. pdp pdp"
      ],
      "set_id": "7f9e9a1e-f2a8-4428-ab9d-9c5b070991eb",
      "id": "e2bac760-6a55-4631-b32c-20a42352011e",
      "effective_time": "20260227",
      "version": "1",
      "openfda": {
        "brand_name": [
          "Lidomax"
        ],
        "generic_name": [
          "LIDOMAX"
        ],
        "manufacturer_name": [
          "Oncora Pharma, LLC"
        ],
        "product_ndc": [
          "85477-304"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "LIDOCAINE"
        ],
        "rxcui": [
          "1011852"
        ],
        "spl_id": [
          "e2bac760-6a55-4631-b32c-20a42352011e"
        ],
        "spl_set_id": [
          "7f9e9a1e-f2a8-4428-ab9d-9c5b070991eb"
        ],
        "package_ndc": [
          "85477-304-07"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0854770304079"
        ],
        "nui": [
          "N0000175682",
          "M0000897",
          "N0000175426",
          "N0000175976"
        ],
        "pharm_class_epc": [
          "Amide Local Anesthetic [EPC]",
          "Antiarrhythmic [EPC]"
        ],
        "pharm_class_cs": [
          "Amides [CS]"
        ],
        "pharm_class_pe": [
          "Local Anesthesia [PE]"
        ],
        "unii": [
          "98PI200987"
        ]
      }
    }
  ]
}